Publication of RGN-259 Phase 3 Clinical Trial Results in Patients with Neurotrophic Keratopathy
ROCKVILLE, Md., Jan. 3, 2023. RegeneRx Biopharmaceuticals, Inc. ( " RegeneRx " or " Company " ), a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today a new scientific publication describing... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 3, 2023 Category: Pharmaceuticals Source Type: clinical trials
RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation
Condition: Chronic Spinal Cord Injury Intervention: Device: RESToration Of Rehabilitative function with Epidural spinal Stimulation Sponsors: National Neuroscience Institute; Agency for Science, Technology and Research; Tan Tock Seng Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
Network Neuro-modulation for Mesial Temporal Lobe Epilepsy
Condition: Mesial Temporal Lobe Epilepsy Interventions: Device: Low Frequency Stimulation (LFS) of site with the Medtronic Percept PC system; Device: Standard of Care (SOC) High Frequency Stimulation of the Anterior Nucleus of the Thalamus (ANT) with the Medtronic Percept PC system Sponsors: The University of Texas Health Science Center, Houston; National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2022 Category: Research Source Type: clinical trials
